NOCI-Prem: Multimodal Approach to the Ontogenesis of Nociception in Very Preterm and Term Infants

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Recruiting
CT.gov ID
NCT05404594
Collaborator
(none)
80
1
2
45
1.8

Study Details

Study Description

Brief Summary

The management of pain related to venipuncture remains insufficient in very preterm infants (VPI. The separation between the mother (father) and her(his) child can aggravate the short-term painful experience of the newborn. Accurate diagnosis and treatment of pain is necessary to preserve the well-being and brain development of VPI. A better understanding of the development of pain pathways and the cortical integration of nociceptive messages is essential to reach this goal.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Maternal vocal contact
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Other
Official Title:
Multimodal Approach to the Ontogenesis of Nociception in Very Preterm and Term Infants
Actual Study Start Date :
Jul 17, 2019
Anticipated Primary Completion Date :
Apr 17, 2023
Anticipated Study Completion Date :
Apr 17, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Very preterm infant

Preterm infant below 33 weeks of GA

Behavioral: Maternal vocal contact
Two consecutive venipuncture (order randomly balanced) within a short period of time will be realized with and without the presence of the mother talking/singing to her VPI infant. In this intervention group, the mother will be supported to talk or to sing to her infants during before and during the venipuncture.

Active Comparator: Full term neonate

Term neonate from a gestational age of 37 weeks.

Behavioral: Maternal vocal contact
Two consecutive venipuncture (order randomly balanced) within a short period of time will be realized with and without the presence of the mother talking/singing to her VPI infant. In this intervention group, the mother will be supported to talk or to sing to her infants during before and during the venipuncture.

Outcome Measures

Primary Outcome Measures

  1. The cortical hemodynamic response profile [During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI]

    The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).

  2. The cortical hemodynamic response profile [During a venipuncture at 34 (+/-2) weeks PMAs in VPI]

    The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).

  3. The cortical hemodynamic response profile [During a venipuncture at 40 (+/-2) weeks PMAs in VPI]

    The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).

  4. The cortical hemodynamic response profile [During a venipuncture at 2 to 3 days of life in term neonates]

    The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).

Secondary Outcome Measures

  1. Comparison of the hemodynamic response profiles and salivary oxytocin levels [During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI]

    Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies

  2. Comparison of the hemodynamic response profiles and salivary oxytocin levels [During a venipuncture at 34 (+/-2) weeks PMAs in VPI]

    Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies

  3. Comparison of the hemodynamic response profiles and salivary oxytocin levels [During a venipuncture at 40 (+/-2) weeks PMAs in VPI]

    Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies

  4. Comparison of the hemodynamic response profiles and salivary oxytocin levels [During a venipuncture at 2 to 3 days of life in term neonates]

    Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies

  5. Analysis of the impact on the responses of maternal separation [During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI]

    Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).

  6. Analysis of the impact on the responses of maternal separation [During a venipuncture at 34 (+/-2) weeks PMAs in VPI]

    Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).

  7. Analysis of the impact on the responses of maternal separation [During a venipuncture at 40 (+/-2) weeks PMAs in VPI]

    Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).

  8. Analysis of the impact on the responses of maternal separation [During a venipuncture at 2 to 3 days of life in term neonates]

    Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).

  9. Comparison of the response profiles according to the sex [During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI]

    Comparison of the response profiles obtained in females and males

  10. Comparison of the response profiles according to the sex [During a venipuncture at 34 (+/-2) weeks PMAs in VPI]

    Comparison of the response profiles obtained in females and males

  11. Comparison of the response profiles according to the sex [During a venipuncture at 40 (+/-2) weeks PMAs in VPI]

    Comparison of the response profiles obtained in females and males

  12. Comparison of the response profiles according to the sex [During a venipuncture at 2 to 3 days of life in term neonates]

    Comparison of the response profiles obtained in females and males

  13. Comparison of conduction velocities of small caliber nociceptive fibers [During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI]

    Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.

  14. Comparison of conduction velocities of small caliber nociceptive fibers [During a venipuncture at 34 (+/-2) weeks PMAs in VPI]

    Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.

  15. Comparison of conduction velocities of small caliber nociceptive fibers [During a venipuncture at 40 (+/-2) weeks PMAs in VPI]

    Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.

  16. Comparison of conduction velocities of small caliber nociceptive fibers [During a venipuncture at 2 to 3 days of life in term neonates]

    Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.

  17. Correlational analyses by APM group [During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI]

    Correlational analyses, by APM group, between the different pain indicators in response to stimulation

  18. Correlational analyses by APM group [During a venipuncture at 34 (+/-2) weeks PMAs in VPI]

    Correlational analyses, by APM group, between the different pain indicators in response to stimulation

  19. Correlational analyses by APM group [During a venipuncture at 40 (+/-2) weeks PMAs in VPI]

    Correlational analyses, by APM group, between the different pain indicators in response to stimulation

  20. Correlational analyses by APM group [During a venipuncture at 2 to 3 days of life in term neonates]

    Correlational analyses, by APM group, between the different pain indicators in response to stimulation

  21. Facial pain behavior [During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI]

    Facial pain behavior with the Neonatal Facial Coding System

  22. Facial pain behavior [During a venipuncture at 34 (+/-2) weeks PMAs in VPI]

    Facial pain behavior with the Neonatal Facial Coding System

  23. Facial pain behavior [During a venipuncture at 40 (+/-2) weeks PMAs in VPI]

    Facial pain behavior with the Neonatal Facial Coding System

  24. Facial pain behavior [During a venipuncture at 2 to 3 days of life in term neonates]

    Facial pain behavior with the Neonatal Facial Coding System

  25. Pain index [During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI]

    Pain index assessing the sympathetic and parasympathetic system

  26. Pain index [During a venipuncture at 34 (+/-2) weeks PMAs in VPI]

    Pain index assessing the sympathetic and parasympathetic system

  27. Pain index [During a venipuncture at 40 (+/-2) weeks PMAs in VPI]

    Pain index assessing the sympathetic and parasympathetic system

  28. Pain index [During a venipuncture at 2 to 3 days of life in term neonates]

    Pain index assessing the sympathetic and parasympathetic system

  29. Cortical evoked potentials [During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI]

    Cortical evoked potentials in Cz according to EEG 10:20 classification

  30. Cortical evoked potentials [During a venipuncture at 34 (+/-2) weeks PMAs in VPI]

    Cortical evoked potentials in Cz according to EEG 10:20 classification

  31. Cortical evoked potentials [During a venipuncture at 40 (+/-2) weeks PMAs in VPI]

    Cortical evoked potentials in Cz according to EEG 10:20 classification

  32. Cortical evoked potentials [During a venipuncture at 2 to 3 days of life in term neonates]

    Cortical evoked potentials in Cz according to EEG 10:20 classification

Eligibility Criteria

Criteria

Ages Eligible for Study:
0 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Experimental group: VPIs of gestational age less than or equal to 33 weeks on the day of birth and hospitalized in the neonatal intermediate care unit or the neonatal intensive care unit of the Neonatal department of the Hautepierre Hospital (Strasbourg University Hospital)

  • Control group: Healthy full-term babies (> 37 weeks gestational age) hospitalized in the maternity ward of Strasbourg University Hospital

  • Consent obtained from both parents

  • Subject affiliated to a social health insurance plan.

Exclusion Criteria:
    • Any malformation known before inclusion
  • Cerebral lesions discovered on cerebral ultrasound performed as part of the standard management of newborns (Intra-Ventricular Hemorrhages of grade III or IV of the Papile classification, Periventricular Leucomalacia)

  • Unstable clinical status according to the investigator's judgment

  • Expected transfer of the child to another hospital before the term of 40 weeks PMAs.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Service de Pédiatrie - Hôpital d'Hautepierre Strasbourg France 67000

Sponsors and Collaborators

  • University Hospital, Strasbourg, France

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT05404594
Other Study ID Numbers:
  • 7256
First Posted:
Jun 3, 2022
Last Update Posted:
Jun 3, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Strasbourg, France
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 3, 2022